Skip to content

Preoperative Volume Substitution in Elective Surgery Patients

Preoperative Volume Substitution in Fasting Patients Undergoing Elective Surgery - Impact on Hemodynamic Stability During Anesthesia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01811966
Enrollment
220
Registered
2013-03-15
Start date
2013-03-31
Completion date
2015-02-28
Last updated
2015-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodynamic Instability, Hypovolemia, Anesthesia

Keywords

preoperative volume substitution, hypovolemia, preoperative fasting

Brief summary

Preoperative fasting can evoke a hypovolemia which may cause a hemodynamic instability during introduction of anesthesia. The purpose of this study is to test the hypothesis that a defined preoperative volume substitution compared to standard procedure will result in a reduced incidence of hemodynamic instabilities during introduction of anesthesia in elective surgery patients.

Detailed description

The preoperative fasting period often lasts longer than 2 hours as recommended by various national and international anesthetic guidelines. Thus, hypovolemia is more often then anticipated. In awake patients this condition is often masked. Introduction of anesthesia often leads to an unmasking of hypovolemia with a consecutive hemodynamic instability. Aim of the study is to test the hypothesis that a preoperative volume substitution (8 ml/kg RingerAcetate Solution in 15 min. prior to introduction of anesthesia) reduces possible hemodynamic instabilities during initiation of anesthesia.

Interventions

OTHERVolume
OTHERControl

Sponsors

Philipps University Marburg
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 years * thyreoid, parathyroid or gallbladder surgery * general anesthesia

Exclusion criteria

* coronary artery disease * congestive heart disease (≥ New York Heart Association (NYHA) 2) * insulin dependent diabetes mellitus * renal insufficiency (creatinine \> 2,0 mg/dl) * cerebrovascular disease * severe hypertension (≥ antihypertensive drugs)

Design outcomes

Primary

MeasureTime frameDescription
hemodynamic instabilityat time of introduction of anesthesiaHemodynamic instability during induction of anesthesia (0-10 min), defined as at least one of the following: * Systolic blood pressure \< 80 mmHg or decrease of 20% in preexistent hypertension * Mean blood pressure \< 50 mmHg or decrease of 20% or \> 20 mmHg in preexistent hypertension * Bradycardia \< 45/min or decrease of 20% in preexistent bradycardia \< 60/min. * Tachycardia \> 120/min * Cardiac index \< 2.0 l/min/m²

Secondary

MeasureTime frameDescription
Stroke volume index > 35 ml/m2at time of anesthesia
Stroke volume variation < 12 %at time of anesthesia
Enddiastolic area (EDA) > 10 cm2at time of anesthesiatransthoracic echocardiographic parasternal short axis enddiastolic area
inferior vana cava diameter (VCI) > 15 mmat time of anesthesiatransthoracic echocardiographic inferior vena cava diameter

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026